Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial

[1]  Teun Bousema,et al.  Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs , 2010 .

[2]  T. Bousema,et al.  Substantial Contribution of Submicroscopical Plasmodium falciparum Gametocyte Carriage to the Infectious Reservoir in an Area of Seasonal Transmission , 2009, PloS one.

[3]  J. Ndiaye,et al.  Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis , 2009, Malaria Journal.

[4]  J. Ndiaye,et al.  Randomized, multicentre assessment of the efficacy and safety of ASAQ – a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria , 2009, Malaria Journal.

[5]  S. Sirima,et al.  The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum , 2009, Malaria Journal.

[6]  A. Talisuna,et al.  Pharmacovigilance of antimalarial treatment in Uganda: community perceptions and suggestions for reporting adverse events , 2008, Tropical medicine & international health : TM & IH.

[7]  A. Souares,et al.  Adherence and effectiveness of drug combination in curative treatment among children suffering uncomplicated malaria in rural Senegal. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[8]  O. Gaye,et al.  Efficacy and safety of artesunate plus amodiaquine in routine use for the treatment of uncomplicated malaria in Casamance, southern Sénégal , 2007, Malaria Journal.

[9]  Oumar Faye,et al.  Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal , 2007, Malaria Journal.

[10]  M. Randrianarivelojosia,et al.  Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union. , 2007, Acta tropica.

[11]  P. Brasseur.  Tolérance de l'amodiaquine. , 2007 .

[12]  U. d’Alessandro,et al.  Pharmacovigilance of antimalarial treatment in Africa: is it possible? , 2006, Malaria Journal.

[13]  R. Hallett,et al.  Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial , 2005, The Lancet.

[14]  D. Warhurst.  A molecular marker for chloroquine-resistant falciparum malaria. , 2001, The New England journal of medicine.

[15]  X. Su,et al.  A molecular marker for chloroquine-resistant falciparum malaria. , 2001, The New England journal of medicine.

[16]  P. Olliaro,et al.  Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. , 1996, Parasitology today.

[17]  R. Price,et al.  Effects of artemisinin derivatives on malaria transmissibility , 1996, The Lancet.

[18]  L. Ranford-Cartwright,et al.  Rapid and simple method for isolating malaria DNA from fingerprick samples of blood. , 1992, Molecular and biochemical parasitology.

[19]  LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE , 1925, Journal of Helminthology.

[20]  P. Brasseur.  [Tolerance of amodiaquine]. , 2007, Medecine tropicale : revue du Corps de sante colonial.

[21]  D. Matsui.  Current Issues in Pediatric Medication Adherence , 2007, Paediatric drugs.

[22]  I. Edwards.  Safety monitoring of new anti-malarials in immediate post-marketing phase. , 1998, Medecine tropicale : revue du Corps de sante colonial.